BioMedNewsBreaks – Grey Cloak Tech Inc. (GRCK) Changes Name, Ticker; Now Healthy Extracts Inc.

Grey Cloak Tech (OTCQB: GRCK) has announced that the company has officially changed its name to Healthy Extracts Inc. The company’s ticker will also change to OTCQB: HYEX. These changes are official today, March 1, 2021. The company is focused on the development of its proprietary natural plant-based formulations; the company is also committed to sales and distribution of cardiovascular and neuro products. Grey Cloak, now Healthy Extracts, has two subsidiaries: Ultimate Brain Nutrients, a science-based company that develops unique, plant-based, high-quality, neuro-products that increase brain health including memory, cognition, focus and neuro-energy; and BergaMet NA, a provider of nutraceutical natural heart health supplements. “The name Healthy Extracts Inc. was an important step in aligning our corporate structure and goals with our proprietary products,” said Healthy Extracts president Duke Pitts in the press release. “We are looking forward to making Healthy Extracts a name to remember.”

To view the full press release, visit https://ibn.fm/mxTNT

About Healthy Extracts Inc. 

Healthy Extracts — through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) — is engaged in proprietary research and development of natural plant-based formulations as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites at www.HealthyExtractsInc.com, www.Bergametna.com and www.UBNutrients.com.

NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at http://ibn.fm/GRCK

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line 

Nutriband (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of…

19 hours ago

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA’s Bioequivalence Program stating no bioequivalence deficiencies were identified at…

2 days ago

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDA Review For NRX-100

NRx Pharmaceuticals (NASDAQ: NRXP) announced that minutes from a Type C meeting with the U.S.…

3 days ago

BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q4 and Full-Year 2025 Results, Highlights Launch of TONMYA(TM)

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated commercial biotechnology company, reported financial results for the…

6 days ago

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful…

6 days ago

BioMedNewsBreaks — Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) Reports 99.67% Share Redemptions Ahead Of VERAXA Biotech Merger

Voyager Acquisition (NASDAQ: “VACHU,” “VACH,” “VACHW”) announced that holders of 25,217,315 Class A ordinary shares — representing approximately 99.67%…

1 week ago